Print

Simulations Plus (SLP) Reports Preliminary Revenues for Fourth Fiscal Quarter and Fiscal Year 2013  
9/9/2013 6:26:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fourth fiscal quarter and fiscal year 2013, ended August 31, 2013 (4QFY13).

Ms. Momoko Beran, chief financial officer of Simulations Plus, stated, “In accordance with our policy to release timely financial information to our shareholders, we are releasing preliminary revenues for 4QFY13.

Help employers find you! Check out all the jobs and post your resume.

//-->